Lupin SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Lupin analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Lupin SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Lupin to benchmark its business & performance as compared to the competitors and industry. As of 2020, Lupin is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Lupin competitors and includes Lupin target market, segmentation, positioning & Unique Selling Proposition (USP).

Lupin SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Lupin Brand Analysis
Parent Company

Lupin
Category

Pharmaceutical
Sector

Pharma and Healthcare
Tagline/ Slogan

Being lupin, enriching lives everyday
USP

Lupin is the world’s largest manufacturer of anti- tuberculosis drugs
Lupin STP
Lupin Segmentation

Anti TB segment, Cardiovascular, Oral and injectable, pediatric products API’s, Anti-Infectives segment
Lupin Target Market

Healthcare professionals, doctors treating patients suffering from TB, respiratory  &  cardiovascular diseases
Lupin Positioning

It is innovation led pharmaceutical company, which specializes in generic, API & branded formulations for developed & developing world.
Lupin SWOT Analysis
Lupin Strengths

Below are the Strengths in the SWOT Analysis of Lupin:

1. World wide leader in Cephalosporin and Anti TB drugs
2. Considerable presence in market for drugs against Asthma, Pediatrics, Diabetes, and CNS boosts the sales
3. In the US and Japanese market it is the largest generic player
4. Acquisition of I’rom pharma helped to increase its product list and in turn sales

5. Wide global footprint as it is present in over 70 countries
Lupin Weaknesses

Here are the weaknesses in the Lupin SWOT Analysis:

1.High dependence on global formulation business with 84% revenue coming from US market
3. Forecasting done on technological level is less

4. It operates in low growth segments such CNS, respiratory diseases
Lupin Opportunities

Following are the Opportunities in Lupin SWOT Analysis:

1.Increased health awareness

2. Emerging technological trends in drug delivery

3. Increasing prevalence of TB in developing countries
Lupin Threats

The threats in the SWOT Analysis of Lupin are as mentioned:

1.Unsuccessful  assimilation of questions

2.Rigid opposition both from locals and global company

3. Soaring cost of discovering novel products
Lupin Competition
Competitors

Below are the top 4 Lupin competitors:

1. Sun pharmaceuticals

2. Ranbaxy

3. Dr. Reddy’s lab

4. Cipla


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Lupin. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin